Antidepressant Use During Early Pregnancy Does Not Increase Risk of Autism or ADHD

A recent study has found that use of antidepressants by the mother during early pregnancy did not significantly increase the risk of poor fetal growth or the child’s risk of developing Autism or ADHD as previously thought. As well, only a slight increased risk for premature birth was found. This is the largest study to…

New BC PharmaCare Coverage Discriminatory to Adults with ADHD

On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric population. Three long acting ADHD medications (Adderall XR, Vyvanse and Strattera) will be added under the Special Authority (SA) program. The SA program covers medications for patients under…

Are we Prescribing too Many Antipsychotic Medications for Children with ADHD?

A recent study by the Institute for Clinical Evaluative Sciences found almost 12 per cent of children and youth with attention deficit hyperactivity disorder, or ADHD, were prescribed antipsychotics like Risperdal, Zyprexa and Seroquel. Since the study found that 5% of Ontario children have ADHD, this means that .06% of children may be receiving antipsychotic…

Follow–up from Health Canada regarding Generic Forms of Concerta

This past week, a follow-up letter was received from Marion Law, the Director General of Health Canada’s Therapeutic Products Directorate (TPD) addressing discussions during the Oct 31 meeting with Janssen, CADDAC  and ADHD medical experts. The letter noted that: During the meeting with Health Canada, concerns were expressed by patient and physician organizations about the…